Test Price
2,800 AED✅ Home Collection Available
SMARCB1 Gene Genetic Test for Intellectual Disability (Autosomal Dominant Type 15) in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation from our expert panel.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The SMARCB1 NGS test screens the complete coding region of the SMARCB1 gene for pathogenic variants linked to autosomal dominant intellectual disability type 15 and associated cancer predisposition syndromes, delivering high-throughput, clinically actionable results.
| Feature | Our Test – SMARCB1 NGS | Closest Alternative – Sanger Sequencing |
|---|---|---|
| Methodology | Next Generation Sequencing (targeted gene panel) | Capillary Sanger sequencing (single gene) |
| Diagnostic Sensitivity | 99.9% (detects SNVs, indels, and copy number variants) | ~95% (limited to point mutations, poor CNV detection) |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403): “Every genetic variant must be contextualized within the full clinical picture. A positive SMARCB1 finding warrants careful correlation with developmental history and imaging; a negative result does not rule out other causes. Multidisciplinary care remains the cornerstone of management.”
Medication Advisory
Do not discontinue any prescribed medication without consulting your doctor. Always seek professional medical advice before making changes to your treatment plan.
Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not appropriate for asymptomatic individuals without a known family history or prior genetic counseling; it is not designed for prenatal diagnosis without explicit specialist referral.
- Exclusion: Patients under 18 years must undergo pre‑test genetic counseling in accordance with UAE legal requirements for pediatric genetic testing.
- Emergency Red Flags: Seek immediate medical attention if the child experiences sudden seizures, rapid loss of developmental milestones, unexplained neurological deterioration, or signs of malignancy such as a growing lump, persistent fever, or weight loss.
This information does not replace individualized clinical judgment. Always consult your treating physician.
Patient FAQ & Clinical Guidance
1. What does the SMARCB1 Genetic Test detect?
The SMARCB1 NGS test accurately identifies pathogenic mutations causing autosomal dominant intellectual disability type 15. This comprehensive analysis examines the entire SMARCB1 gene sequence, enabling precise diagnosis, recurrence risk assessment, and surveillance for associated conditions such as rhabdoid tumor predisposition syndrome in at‑risk families.
2. How is the test performed and what is the turnaround time?
A simple blood draw or FTA card spot is collected by our VIP Mobile Phlebotomist, then processed using NGS technology. Results are available within 3–4 weeks. Pre‑test genetic counseling is mandatory for minors.
3. Is the SMARCB1 NGS covered by insurance in the UAE?
Most UAE insurers provide coverage for genetic testing when medically indicated. Our team verifies direct billing eligibility through WhatsApp before sample collection, minimizing out‑of‑pocket expenses. We handle pre‑authorization and submit the required genetic counseling report in accordance with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled with strict confidentiality and security. Clinical safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | SMARCB1 Gene Genetic Test (Intellectual Disability Autosomal Dominant Type 15) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral Blood, DNA, or FTA Card Spot (Whole Blood) |
| Methodology Used | Next Generation Sequencing (NGS) – Targeted Gene Panel |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 87613-9 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians